Recursion Pharmaceuticals Files 8-K on Equity Sales
Ticker: RXRX · Form: 8-K · Filed: Jul 8, 2025 · CIK: 1601830
| Field | Detail |
|---|---|
| Company | Recursion Pharmaceuticals, Inc. (RXRX) |
| Form Type | 8-K |
| Filed Date | Jul 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, filing, regulation-fd
Related Tickers: RXRX
TL;DR
Recursion Pharma filed an 8-K for unregistered equity sales - watch for dilution.
AI Summary
Recursion Pharmaceuticals, Inc. filed an 8-K on July 8, 2025, reporting on unregistered sales of equity securities, Regulation FD disclosures, and other events. The filing also includes financial statements and exhibits, with the company's principal executive offices located at 41 S Rio Grande Street, Salt Lake City, UT 84101.
Why It Matters
This filing indicates potential new equity issuance, which could impact share dilution and company capitalization.
Risk Assessment
Risk Level: medium — Unregistered equity sales can sometimes signal financial needs or dilution concerns for existing shareholders.
Key Players & Entities
- Recursion Pharmaceuticals, Inc. (company) — Registrant
- July 8, 2025 (date) — Date of Report
- 41 S Rio Grande Street, Salt Lake City, UT 84101 (location) — Principal Executive Offices
FAQ
What specific type of equity securities were sold unregistered?
The filing mentions 'Unregistered Sales of Equity Securities' as an item of disclosure but does not specify the type of securities in the provided text.
Were there any material events disclosed under Regulation FD?
The filing lists 'Regulation FD Disclosure' as an item, but the specific details of any such disclosures are not present in the provided text.
What is the significance of the 'Other Events' item?
The filing indicates 'Other Events' are being reported, but the nature of these events is not detailed in the provided excerpt.
When was Recursion Pharmaceuticals, Inc. incorporated?
The company is incorporated in Delaware, as indicated by the filing.
What is Recursion Pharmaceuticals' SIC code?
The Standard Industrial Classification (SIC) code for Recursion Pharmaceuticals, Inc. is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding RECURSION PHARMACEUTICALS, INC. (RXRX).